AKT/ERK-mediated activation of CDK7-MED1-AR axis drives resistance to pan BET bromodomain inhibitor ZEN-3694 in advanced prostate cancer [RNA-Seq]
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP361766
下载链接
链接失效反馈官方服务：
资源简介：
Prostate cancer cells were cultured in the presence of the drug Zenith-3694 for a period of 16-20 weeks to develop drug-resistant cells and subjected to RNA sequencing. Overall design: Comparison of three different prostate cancer cell lines (VCAP, LNCAP, 22RV1) upon acquiring drug resistance.
创建时间：
2022-03-05
